Yi‐Fang Yang

701 total citations
29 papers, 505 citations indexed

About

Yi‐Fang Yang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yi‐Fang Yang has authored 29 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yi‐Fang Yang's work include Cancer, Hypoxia, and Metabolism (9 papers), Epigenetics and DNA Methylation (6 papers) and Ferroptosis and cancer prognosis (3 papers). Yi‐Fang Yang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (9 papers), Epigenetics and DNA Methylation (6 papers) and Ferroptosis and cancer prognosis (3 papers). Yi‐Fang Yang collaborates with scholars based in Taiwan, United Kingdom and China. Yi‐Fang Yang's co-authors include Michael Hsiao, Yu‐Chan Chang, Chih‐Jen Yang, Yi‐Hua Jan, Ming-Shyan Huang, Jean Chiou, Yi‐Chen Lee, Tsung‐Ching Lai, Yuan‐Feng Lin and Shyng‐Shiou F. Yuan and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and Cancer Research.

In The Last Decade

Yi‐Fang Yang

27 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yi‐Fang Yang Taiwan	12	357	224	102	73	68	29	505
Jingping Ge China	10	368 1.0×	193 0.9×	67 0.7×	54 0.7×	102 1.5×	38	588
Haiping Pei China	13	321 0.9×	199 0.9×	141 1.4×	47 0.6×	70 1.0×	20	525
Haoyi Jin China	13	402 1.1×	299 1.3×	108 1.1×	66 0.9×	78 1.1×	19	541
Floriane Pez France	5	288 0.8×	120 0.5×	92 0.9×	45 0.6×	48 0.7×	6	431
Zhenbo Tu China	14	328 0.9×	237 1.1×	158 1.5×	106 1.5×	82 1.2×	22	520
Hai Hu China	9	350 1.0×	110 0.5×	107 1.0×	85 1.2×	47 0.7×	10	475
Zhihong Ai China	12	427 1.2×	275 1.2×	117 1.1×	88 1.2×	53 0.8×	23	648
Zhuonan Zhuang China	9	213 0.6×	147 0.7×	150 1.5×	97 1.3×	42 0.6×	16	410
Kai‐Yu Ng Hong Kong	9	402 1.1×	235 1.0×	130 1.3×	46 0.6×	55 0.8×	11	542

Countries citing papers authored by Yi‐Fang Yang

Since Specialization

Citations

This map shows the geographic impact of Yi‐Fang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Fang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Fang Yang more than expected).

Fields of papers citing papers by Yi‐Fang Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Fang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Fang Yang. The network helps show where Yi‐Fang Yang may publish in the future.

Co-authorship network of co-authors of Yi‐Fang Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Fang Yang. A scholar is included among the top collaborators of Yi‐Fang Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Fang Yang. Yi‐Fang Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kuo, Wei‐Ting, et al.. (2025). Sulfatase modifying factor 2 as a predictive biomarker for urothelial carcinoma. Discover Oncology. 16(1). 126–126.

Lin, Yu‐Hsuan, et al.. (2025). Alda‑1 restores ALDH2‑mediated alcohol metabolism to inhibit the NF‑κB/VEGFC axis in head and neck cancer. International Journal of Molecular Medicine. 55(4).

Tsai, Kuo‐Wang, Yi‐Fang Yang, Liang‐Jen Wang, et al.. (2024). Correlation of potential diagnostic biomarkers (circulating miRNA and protein) of bipolar II disorder. Journal of Psychiatric Research. 172. 254–260. 2 indexed citations

Lee, Yi‐Chen, et al.. (2024). PTGES is involved in myofibroblast differentiation via HIF‐1α‐dependent glycolysis pathway. Journal of Cellular and Molecular Medicine. 28(20). e70157–e70157. 2 indexed citations

Chang, Yu‐Chan, Yi‐Fang Yang, Chien‐Hsiu Li, et al.. (2024). RAB31 drives extracellular vesicle fusion and cancer‐associated fibroblast formation leading to oxaliplatin resistance in colorectal cancer. SHILAP Revista de lepidopterología. 3(2). e141–e141. 2 indexed citations

Kuo, Wei‐Ting, Yi-Chen Lee, Yi‐Fang Yang, et al.. (2024). Sushi Domain Containing 2 Dysfunction Contributes to Cancer Progression in Patients with Bladder Cancer. Journal of Cancer. 15(16). 5318–5328. 2 indexed citations

Hu, Wan‐Chung, Yi‐Fang Yang, Ching‐Feng Cheng, et al.. (2024). Overexpression of malic enzyme is involved in breast cancer growth and is correlated with poor prognosis. Journal of Cellular and Molecular Medicine. 28(6). e18163–e18163. 5 indexed citations

Lin, Yu‐Hsuan, et al.. (2023). Analysis of Aldehyde Dehydrogenase 2 as a Prognostic Marker Associated with Immune Cell infiltration and Chemotherapy Efficacy in Head and Neck Squamous Cell Carcinoma. Journal of Cancer. 14(10). 1689–1706. 2 indexed citations

Lee, Yi‐Chen, Kuo‐Wang Tsai, Jia-Bin Liao, et al.. (2022). High expression of tight junction protein 1 as a predictive biomarker for bladder cancer grade and staging. Scientific Reports. 12(1). 1496–1496. 11 indexed citations

10.

Yang, Yi‐Fang, et al.. (2022). UBE2C triggers HIF‐1α‐glycolytic flux in head and neck squamous cell carcinoma. Journal of Cellular and Molecular Medicine. 26(13). 3716–3725. 11 indexed citations

11.

Lin, Yu‐Hsuan, Yi‐Fang Yang, & Yow‐Ling Shiue. (2022). Multi-Omics Analyses to Identify FCGBP as a Potential Predictor in Head and Neck Squamous Cell Carcinoma. Diagnostics. 12(5). 1178–1178. 7 indexed citations

12.

Huang, Ming‐Shyan, et al.. (2021). Potential Clinical Value of 5-Hydroxytryptamine Receptor 3C as a Prognostic Biomarker for Lung Cancer. Journal of Oncology. 2021. 1–9. 3 indexed citations

13.

Yeh, Chih‐Ching, et al.. (2021). SERPINE2 Overexpression Is Associated with Poor Prognosis of Urothelial Carcinoma. Diagnostics. 11(10). 1928–1928. 10 indexed citations

14.

Kung, Mei‐Lang, et al.. (2020). The Long Noncoding RNA LOC441461 (STX17-AS1) Modulates Colorectal Cancer Cell Growth and Motility. Cancers. 12(11). 3171–3171. 13 indexed citations

15.

Yang, Yi‐Fang, Yen‐Yun Wang, Michael Hsiao, et al.. (2020). IMPAD1 functions as mitochondrial electron transport inhibitor that prevents ROS production and promotes lung cancer metastasis through the AMPK-Notch1-HEY1 pathway. Cancer Letters. 485. 27–37. 16 indexed citations

16.

Yang, Yi‐Fang, Yu‐Chan Chang, Yi‐Hua Jan, et al.. (2020). Squalene synthase promotes the invasion of lung cancer cells via the osteopontin/ERK pathway. Oncogenesis. 9(8). 78–78. 34 indexed citations

17.

Chang, Yu‐Chan, Yi‐Fang Yang, Jean Chiou, et al.. (2020). Nonenzymatic function of Aldolase A downregulates miR-145 to promote the Oct4/DUSP4/TRAF4 axis and the acquisition of lung cancer stemness. Cell Death and Disease. 11(3). 195–195. 29 indexed citations

18.

Yang, Yi‐Fang, Yi‐Chen Lee, Yen‐Yun Wang, et al.. (2019). YWHAE promotes proliferation, metastasis, and chemoresistance in breast cancer cells. The Kaohsiung Journal of Medical Sciences. 35(7). 408–416. 34 indexed citations

19.

Yang, Yi‐Fang, et al.. (2018). A positive feedback loop of IL-17B-IL-17RB activates ERK/β-catenin to promote lung cancer metastasis. Cancer Letters. 422. 44–55. 36 indexed citations

20.

Yang, Yi‐Fang, Yi‐Hua Jan, Yu‐Peng Liu, et al.. (2014). Squalene Synthase Induces Tumor Necrosis Factor Receptor 1 Enrichment in Lipid Rafts to Promote Lung Cancer Metastasis. American Journal of Respiratory and Critical Care Medicine. 190(6). 675–687. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact